Wednesday, February 16, 2011

New Biotech Company Will Focus on Clinical Development of Novel Diabetes Drug

Index Ventures and Amunix Invest in Diartis Pharmaceuticals. Diartis Pharmaceuticals, Inc., a newly founded biotechnology company, announced today that it has received initial funding from Index Ventures, Amunix Inc., a U.S. based biotechnology company, and private investors.

Other details on
www.marketwire.com/press-release/Index-Ventures-and-Amunix-Invest-in-Diartis-Pharmaceuticals-1396681.htm

No comments:

Post a Comment